Publication
Published papers
Comparative oncology: overcoming human cancer through companion animal studies
Oh JH and Cho J-Y†
Experimental & Molecular Medicine. 2023
BRIC 한빛사. 2023
Experimental & Molecular Medicine. 2023
BRIC 한빛사. 2023
Akt1 decreases Gcn5 protein stability through regulating the ubiquitin-proteasome pathway in mouse embryonic fibroblasts.
Jeong DS, Kim YC, Oh JH†, and Kim MH†
Cell Journal. 2022
Cell Journal. 2022
HOXB5 confers tamoxifen resistance in breast cancer cells and promotes tumor aggression and progression.
Kim CY, Kim YC, Oh JH†, and Kim MH†
Anticancer Research. 2021
Anticancer Research. 2021
NR4A1 regulates tamoxifen resistance by suppressing ERK signaling in ER-positive breast cancer.
Kim CY, Kim YC, Oh JH†, and Kim MH†
Cells, 2021
Cells, 2021
HOXA5 confers tamoxifen resistance via the PI3K/AKT signaling pathway in ER-positive breast cancer
Kim CY, Kim YC, Oh JH†, and Kim MH†
Journal of Cancer. 2021
Journal of Cancer. 2021
Elevated GCN5 expression confers tamoxifen resistance by upregulating AIB1 expression in ER-positive breast cancer.
Oh JH, Lee J-Y, Kim KH, Kim CY, Jeong DS, Cho Y, Nam KT†, and Kim MH†
Cancer Letters. 2020
Cancer Letters. 2020